• Home
  • News
  • Portfolio News
  • Skyline Medical (Formerly Known as BioDrain Medical, Inc.) Reports Third Quarter 2016 Financial Results

Skyline Medical (Formerly Known as BioDrain Medical, Inc.) Reports Third Quarter 2016 Financial Results

16Nov

Skyline Medical (Formerly Known as BioDrain Medical, Inc.) Reports Third Quarter 2016 Financial Results

Portfolio News

Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), developer of the innovative STREAMWAY® waste fluid disposal system for medical applications, reports financial results for the three and nine months ended September 30, 2016. Read more >>

Share this post

Related Posts

13Apr

Pyramid Biosciences Announces TIME Trial™ Program Collaboration with Tempus for Patients with NTRK Fusion Solid Tumors

Pyramid Biosciences, Inc., a clinical-stage biotechnology company developing a portfolio of precision therapies targeting a range of serious diseases, today... read more
10Dec

Disruptive tech for vision-impaired: Gregory Ogorek, COO & president of eSight

Vision impairment and blindness caused by diseases such as glaucoma and age-related macular degeneration (AMD) is a concern and potential... read more
03Nov

In focus: Anchorage 6th grader sees clearly for the first time thanks to new tech, community support

Imagine the whole world around you is a blur. That was reality for an Anchorage sixth grader who is now... read more
06Mar

Yorkton woman regains vision through new technology

A Yorkton woman got the gift of sight thanks to some new technology and the support of her community. read more
11Jul

Regroup Mass Notification Partners with MiCTA to Offer Mass Notification Solutions to Members

Regroup Mass Notification, the award-winning leader in emergency and day-to-day mass notification technology, and MiCTA, expert providers of integrated technology... read more
03Apr

Quthero Welcomes Dr. Omar Ibrahimi as Chief Medical Director

Quthero, a pioneering biotech company renowned for its unique Q-peptide platform technology, welcomes Omar Ibrahimi, MD, PhD, a world-renowned dermatologist,... read more
06Apr

Xylyx Bio collaboration reveals new insights into tumor drug resistance

Xylyx Bio develops physiologic disease models that enable researchers to gain insights into tumor biology and evaluate the efficacy of... read more
18Oct

Immusoft Reports Promising Early Data for Lead Candidate in MPS I

Nearly a year after making cell therapy history by dosing the first patient with the first engineered B cell in... read more
10Feb

Carbonite to acquire endpoint security company Webroot for $618.5M

Carbonite, the online backup and recovery company based in Boston, announced late yesterday that it will be acquiring Webroot, an... read more
10Dec

Legally blind Canadian using electronic glasses to develop more accessible apps

...Through the Canadian National Institute for Blindness’ (CNIB) scholarship program, Pope has been awarded the eSight 4, a wearable medical... read more